XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (2,040,632) $ 45,995
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 68,528 105,982
Amortization of debt discount on notes payable 6,127 159,791
Amortization of right of use assets 42,050 341,384
Gain on debt extinguishment 0 (754,000)
Share-based payment compensation 27,286 9,168
Recovery of returns and doubtful accounts (18,740) 0
Deferred income taxes 0 7,139
Changes in operating assets and liabilities:    
Accounts receivable 1,309,794 667,748
Prepaid expenses and other current assets (59,132) 302,404
Contract assets 51,502 38,016
Inventory 7,291 0
Other assets 4,925 (269)
Accounts payable 301,761 102,950
Accrued expenses and other long-term liabilities 106,945 (521,676)
Operating lease liabilities (42,050) (468,821)
Deferred revenue (1,075,349) (381,096)
Net cash provided by (used in) operating activities (1,309,694) (345,285)
Cash flows from investing activities:    
Purchases of property and equipment 0 (60,444)
Security deposits 0 739,484
Payments to Develop Software (35,000) 0
Purchase of intangible assets (3,078) (10,436)
Net cash provided by (used in) investing activities (38,078) 668,604
Cash flows from financing activities:    
Proceeds from public offering, net of underwriting discounts paid 0 3,095,203
Payments of offering costs 0 (265,252)
Payments of short-term debt 0 (1,334,058)
Net cash provided by (used in) financing activities 0 1,495,893
Effect of exchange rate changes on cash and cash equivalents (25,319) 1,732
Net increase (decrease) in cash and cash equivalents (1,373,091) 1,820,944
Cash and cash equivalents, beginning of period 3,181,209 1,920,656
Cash and cash equivalents, end of period 1,808,118 3,741,600
Supplemental disclosures:    
Cash paid for interest 43,224 86,860
Non-cash investing and financing activities:    
Accrual of deferred offering costs 0 92,181
Undistributed Series A redeemable convertible preferred stock dividends 639,349 560,096
Accretion of Series A redeemable convertible preferred stock $ 50,397 $ 272,297